中国中医药产业升级路径选择——基于全球价值链视角

Study on the Upgrade Path Choice of Chinese Medicine Industry

随着世界经济深度一体化,嵌入全球价值链的中医药产业面临着前所未有的机遇和挑战,而自主创新能力不足、产业优化升级困难、知识产权保护意识不强等原因,严重制约着中医药产业的可持续发展。积极构建自主创新体系,提高持续创新能力,加强社会信用制度供给,走集群化发展模式等一系列的措施与制度安排,是中医药产业可持续发展的现实路径选择。

With the deep global integration of economy, the Chinese medicine industry, which has been embedded into global value chain, is confronted with unprecedented opportunities and challenges. Suffering from the problems, such as shortage of independent innovation capability, difficulties in industry upgrade and optimization, lacking of awareness of the independent intellectual property rights protection, the sustainable development of CMI is severely dragged. Actively establishing independent innovation system, improving the sustainable innovation ability, strengthening the soci＇al credit system supply, and stepping the cluster development mode and so on a series of measures and system arrangement are the realistic choices of the CMI sustainable development.